Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections.
By M. Sohail, D. Uslan, Akbar H. Khan, P. Friedman, D. Hayes, W. Wilson, J. Steckelberg, Sarah M. Stoner, L. Baddour. Journal of the American College of Cardiology, 2007
729 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Microbiology
View Paper: https://www.semanticscholar.org/paper/a9e4bd4acbecb39590acf3cb79e465ec918d3624
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. (2011, background): “CIED infection is associated with high patient morbidity and a mortality rate of up to 18% (8,9,16,17).”
- GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) (2010, neutral): “LDI is defined as an infection limited to the pocket of the CD and is clinically suspected in the presence of local signs of inflammation at the generator pocket, including erythema, warmth, fluctuance, wound dehiscence, erosion, tenderness, or purulent drainage.(300) CDRIE is defined as an infectio”